Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-dependent RNA helicase DDX1 (DDX1) is a member of the DEAD-box family of RNA helicases defined by the conserved Asp-Glu-Ala-Asp (DEAD) motif[1]. It is an enzyme that hydrolyzes ATP to unwind and remodel RNA and is involved in most stages of RNA metabolism, including transcription, splicing, ribosome synthesis, and mRNA stability and decay[1][2][3][4]. DDX1 is distinct among DEAD-box proteins for containing both the Q motif (important for ATP binding and hydrolysis) and a unique SPRY domain (involved in protein-protein recognition)[1]. DDX1 localizes predominantly to the nucleus, often in nucleoplasmic foci associated with the cleavage and polyadenylation of pre-mRNAs, but can also be found in the cytoplasm of certain transformed or overexpressing cells[1][3][4]. It is a component of several ribonucleoprotein complexes, participates directly in the 3' end processing of mRNA through interactions with factors like CstF-64, and plays additional roles in DNA repair, immune sensing of viral RNA, and miRNA maturation[1][3][4]. DDX1 is implicated in cancer—both through overexpression (notably in retinoblastoma and others) and its broader involvement in RNA processing pathways essential for cell proliferation[4]. There are currently no well-established drugs that directly target DDX1, and clinical use is limited by its essential role in diverse cellular processes[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-dependent RNA helicase DDX1 (DDX1).